SC
PBYI icon

Steven Cohen’s Puma Biotechnology PBYI Stock Holding History

Steven Cohen’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,000
Closed -$34K – 2624
2023
Q1 		$34K Buy
+11,000
New +$41.5K ﹤0.01% 1863
2020
Q1 		– Sell
-411,978
Closed -$3.6M – 1008
2019
Q4 		$3.6M Sell
411,978
-94,243
-19% -$780K 0.02% 539
2019
Q3 		$5.45M Buy
506,221
+267,048
+112% +$2.88M 0.03% 438
2019
Q2 		$3.04M Buy
239,173
+237,773
+16,984% +$5.48M 0.02% 596
2019
Q1 		$54K Sell
1,400
-151,758
-99% -$4.63M ﹤0.01% 966
2018
Q4 		$3.12M Sell
153,158
-611,432
-80% -$18.4M 0.02% 648
2018
Q3 		$35.1M Sell
764,590
-155,185
-17% -$7.48M 0.14% 194
2018
Q2 		$54.4M Sell
919,775
-361,342
-28% -$20.9M 0.22% 130
2018
Q1 		$87.2M Buy
1,281,117
+1,020,265
+391% +$76.4M 0.36% 64
2017
Q4 		$25.8M Sell
260,852
-221,348
-46% -$24.8M 0.11% 254
2017
Q3 		$57.7M Buy
482,200
+350,300
+266% +$32.6M 0.26% 101
2017
Q2 		$11.5M Buy
+131,900
New +$7.38M 0.06% 355
2016
Q4 		– Sell
-1,028,706
Closed -$69M – 804
2016
Q3 		$69M Sell
1,028,706
-387,094
-27% -$19.6M 0.49% 35
2016
Q2 		$42.2M Buy
1,415,800
+258,100
+22% +$8.07M 0.29% 91
2016
Q1 		$34M Buy
1,157,700
+212,222
+22% +$9.59M 0.26% 104
2015
Q4 		$74.1M Buy
945,478
+391,459
+71% +$30.7M 0.61% 29
2015
Q3 		$41.8M Buy
554,019
+485,419
+708% +$45.9M 0.33% 90
2015
Q2 		$8.01M Buy
68,600
+59,500
+654% +$10.8M 0.06% 367
2015
Q1 		$2.15M Buy
+9,100
New +$1.95M 0.01% 551
2014
Q3 		– Sell
-327,900
Closed -$21.6M – 733
2014
Q2 		$21.6M Buy
+327,900
New +$23.3M 0.14% 197

Other funds holding PBYI

CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $783M AUM 81.58% 1-Year Est. Return

Steven Cohen's PBYI Position: Q2 2023 in Review

Steven Cohen sold out of Puma Biotechnology (PBYI) in Q2 2023, closing a stake of 11,000 shares — an estimated $34K sold.

Steven Cohen first reported a position in PBYI in Q2 2014 and held it in 20 quarters. The position peaked at $87.2M in Q1 2018. 68 funds tracked by Wall St. Rank hold PBYI as of Q2 2023.

  • Steven Cohen reported no remaining Puma Biotechnology position as of Q2 2023 after selling out during the quarter.
  • Steven Cohen sold 11,000 Puma Biotechnology shares in Q2 2023, an estimated $34K.
  • Steven Cohen first reported a position in Puma Biotechnology in Q2 2014 and held it in 20 quarters.
  • Steven Cohen's Puma Biotechnology position peaked at $87.2M in Q1 2018.
  • 68 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.